在慢性病-矿物质骨疾病中,向患者结局试验的发展势头
相关实验视频
Updated: May 20, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
424
Varsha Pothula Venkata1, Julia J Scialla1,2
1Department of Medicine.
Current opinion in nephrology and hypertension
|May 19, 2025
概括
慢性病矿物质和骨疾病 (CKD-MBD) 的临床试验缺乏关注死亡率等关键结果. 需要更多的研究来确认密集性CKD-MBD治疗是否可以改善患者的生存率并减少心血管事件.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
背景情况:
- 慢性病矿物质和骨疾病 (CKD-MBD) 影响患有衰竭的患者.
- 目前的CKD-MBD治疗主要针对生化标志物,而不是关键的临床结果.
研究的目的:
- 评估关于高优先级临床结果的CKD-MBD治疗现有临床试验证据.
- 讨论设计CKD-MBD未来临床试验的策略.
主要方法:
- 对临床试验证据的审查,重点关注CKD-MBD治疗方法.
- 对试验结果的分析,区分生化,代孕和临床重要终点.
- 考虑对甲状腺前激素 (PTH) 标的观察性研究和试验模拟.
主要成果:
- 大多数CKD-MBD试验评估生化结果;很少有人检查代孕结果,更少的人关注死亡率,心血管事件或住院治疗.
- 在LANDMARK试验中,在碳酸和基于的酸盐结合剂之间的心血管结果中没有显著差异.
- 观测数据表明低PTH目标的潜在益处,但需要通过专门的试验来确认.
结论:
- 对CKD-MBD的强化治疗有望改善功能衰竭患者的临床结果.
- 需要精心设计的临床试验来确认CKD-MBD干预措施对死亡率和心血管疾病的好处.
相关概念视频
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
35
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
35
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Factors Affecting Renal Clearance: Renal Impairment
40
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
40

